Is MARS system enough for A.phalloides-induced liver failure treatment?

Human and Experimental Toxicology

Volumn 29, Issue 10, 2010, Pages 823-832

  Sorodoc, Laurentiu ^a   Lionte, Catalina ^a   Sorodoc, Victorita ^a   Petris, Ovidiu ^a   Jaba, Irina ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Amanita phalloides; liver failure; MARS

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMMONIA; BILIRUBIN;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN DIALYSIS; AMANITA PHALLOIDES; AMMONIA BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; INTENSIVE CARE; LIVER FAILURE; MOLECULAR ABSORBENTS RECIRCULATING SYSTEM; MORTALITY; MUSHROOM POISONING; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; SAFETY; SURVIVAL RATE; THERAPY;

ADOLESCENT; ADULT; AMANITA; EXTRACORPOREAL CIRCULATION; FEMALE; GLASGOW COMA SCALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE, ACUTE; MIDDLE AGED; MUSHROOM POISONING; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SORPTION DETOXIFICATION; TREATMENT OUTCOME;

AMANITA PHALLOIDES; BASIDIOMYCOTA;

EID: 78649959140     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110363327     Document Type: Article

References (51)

1. Tan HK Molecular adsorbent recirculating system (MARS). Ann Acad Med Singapore 2004 ; 33: 329-335.
2. Sherlock S., Dooley J. Diseases of the liver and biliary system. 9 th edn. Oxford: Blackwell Scientific Publications, 1993.
3. Novelli G., et al. MARS (molecular adsorbent recirculating system): experience in 34 cases of acute liver failure. Liver 2002 ; 22: 43-47.
4. Covic A., et al. Successful use of molecular absorbent regenerating system (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 2003 ; 23: 21-27.
5. Lionte C., Hurjui J., Teleman S. Hypoglycemia in acute mushrooms poisoning. Rev Med Chir Soc Med Nat Iasi 2004 ; 108: 281-285.
6. Stange J., et al. Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl 2000 ; 6: 603-613.
7. Gill RQ, Sterling RK Acute liver failure. J Clin Gastroenterol 2001 ; 33: 191-198.
8. Donnelly M., Wax P. Cyclopeptide-containing mushrooms: the deadly amanita mushrooms. In: Brent J, Wallace K, Burkhart K, Phillips S, Ward Donovan J (eds) Critical care toxicology: diagnosis and management of the critically poisoned patient. Philadelphia: Elsevier Mosby, 2005: 127. 7-1286.
9. Lionte C., et al. Clinical, morphological and therapeutic aspects in acute poisoning with Amanita Phalloides. Ther Pharmacol Clin Toxicol 2002 ; VI: 9-16.
10. Aji DY, et al. Haemoperfusion in Amanita phalloides poisoning. J Trop Pediatr 1995 ; 41: 371-374.
11. Scheurlen C., et al. Amanita phalloides intoxications in a family of russian immigrants. Case reports and review of the literature with a focus on orthotopic liver transplantation. Zeitschrift für Gastroenterologie 1994 ; 32: 399-404.
12. Rubik J., et al. Successful treatment of a child with fulminant liver failure and coma caused by Amanita phalloides intoxication with albumin dialysis without liver transplantation. Pediatr Transpl 2004 ; 8: 295-300.
13. Wu BF, Wang MM Molecular adsorbent recirculating system in dealing with maternal Amanita poisoning during the second pregnancy trimester: a case report. Hepatobiliary Pancreat Dis Int 2004 ; 3: 152-154.
14. Catalina MV, et al. Liver failure due to mushroom poisoning: clinical course and new treatment perspectives. Gastroenterol Hepatol 2003 ; 26: 417-420.
15. Shi Y., et al. MARS: optimistic therapy method in fulminant hepatic failure secondary to cytotoxic mushroom poisoning - a case report. Liver 2002 ; 22: 78-80.
16. Lionte C., Sorodoc L., Simionescu V. Successful treatment of an adult with Amanita phalloides-induced fulminant liver failure with Molecular Adsorbent Recirculating System (MARS). Rom J Gastroenterol 2005 ; 14: 267-271.
17. Sein Anand J., Chodorowski Z., Winiewski M., Waldman W. The assessment of albumin liver dialysis - MARS efficacy in the treatment of Amanita phalloides poisoning. Przegl Lek 2007 ; 64: 255-257.
18. Sein Anand J., Chodorowsk Z., Hydzik P. Molecular adsorbent recirculating system - MARS as a bridge to liver transplantation in amanita phalloides intoxication. Przegl Lek 2005 ; 62: 480-481.
19. Hydzik P., et al. Liver albumin dialysis (MARS) - treatment of choice in Amanita phalloides poisoning? Przegl Lek 2005 ; 62: 475-479.
20. Stange J., Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patient"s blood and a bioartificial liver. Int J Artif Organs 1996 ; 19: 677-691.
21. Stange J., et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999 ; 23: 319-330.
22. Mitzner SR, et al. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001 ; 12: S75 - S82.
23. Lamesch P., et al. Molecular adsorbents recirculating system in patients with liver failure. Transpl Proc 2001 ; 33: 3480-3482.
24. Pugh RN, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973 ; 60: 646-649.
25. Kamath PS, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001 ; 33: 464-470.
26. Jalan R., et al. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003 ; 38: 24-31.
27. Faulstich H. New aspects of Amanita poisoning. Klin Wochenschr 1979 ; 57: 1143-1152.
28. Himmelmann A., Mang G., Schnorf-Huber S. Lethal ingestion of stored Amanita phalloides mushrooms. Swiss Med Wkly 2001 ; 131: 616-617.
29. Vesconi S., et al. Therapy of cytotoxic mushroom intoxication. Crit Care Med 1985 ; 13: 402-406.
30. Christen Y., Minazio P., de Moerloose P. Monitoring of haemostatic parameters in five cases of Amanita phalloides poisoning. Blood Coagul Fibrinolysis 1993 ; 4: 627-630.
31. Zawadzki J., Jankowska I., Moszczynska A., Januszewicz P. Hypouricemia due to increased tubular secretion of urate in children with Amanita phalloides poisoning. Nephron 1993 ; 65: 375-380.
32. O'Brien BL, Khuu L. A fatal Sunday brunch: Amanita mushroom poisoning in a Gulf Coast family. Am J Gastroenterol 1996 ; 91: 581-583. (Pubitemid 26083568)
33. Rahman T., Hodgson H. Clinical management of acute hepatic failure. Intensive Care Med 2001 ; 27: 467-476.
34. Stockmann HB, Ijzermans JN Prospects for the temporary treatment of acute liver failure. Eur J Gastroenterol Hepatol 2002 ; 14: 195-203.
35. Bernuau J., Benhamou JP Fulminant and subfulminant hepatic failure. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Volume 2. 1 st edn. Oxford: Oxford Univ Press, 1991.
36. Mitzner SR, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000 ; 6: 277-286.
37. Jalan R., Sen S., Williams R. Prospects for extracorporeal liver support. Gut 2004 ; 53: 890-898.
38. Steiner C., Mitzner S. Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry. Liver 2002 ; 22: 20-25.
39. Awad SS, et al. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 2001 ; 130: 354-362.
40. Jalan R., Williams R. Improvement of cerebral perfusion after MARS therapy: Further clues about the pathogenesis of hepatic encephalopathy? Liver Transpl 2001 ; 7: 713-715.
41. Kreymann B., et al. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatology 1999 ; 31: 1080-1085.
42. Kapoor D., Williams R., Jalan R. MARS: a new treatment for hepatorenal failure. Molecular adsorbent and recirculating system. Gastroenterology 2000 ; 119: 1799-1800.
43. Mitzner S., et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher 2001 ; 5: 417-422.
44. Kellersmann R., et al. Application of molecular adsorbent recirculating system in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences. Liver 2002 ; 22: 56-58.
45. Sorkine P., et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001 ; 29: 1332-1336. (Pubitemid 32641793)
46. Voiculescu M., et al. Successful application of MARS therapy in a 7 year-old patient with hepatic chronic rejection and severe cholestatic syndrome. Rom J Gastroenterol 2002 ; 11: 135-140.
47. Escudié L., et al. Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol 2007 ; 46: 466-473.
48. Faybik P., et al. Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning. Liver Int 2003 ; 23: 28-33.
49. Kantola T., et al. Early molecular adsorbents recirculating system treatment of Amanita mushroom poisoning. Ther Apher Dial 2009 ; 13: 399-403.
50. Sein Anand J., Chodorowski Z., Winiewski M., Waldman W. The assessment of albumin liver dialysis-MARS efficacy in the treatment of Amanita phalloides poisoning. Przegl Lek 2007 ; 64: 255-257.
51. Hydzik P., et al. Liver albumin dialysis (MARS) - treatment of choice in Amanita phalloides poisoning? Przegl Lek 2005 ; 62: 475-479.